Peripheral neuropathy associated with eosinophilia-myalgia syndrome
β Scribed by Dr T. D. Heiman-Patterson; S. J. Bird; G. J. Parry; J. Varga; M. E. Shy; N. W. Culligan; L. Edelsohn; G. T. Tatarian; M. P. Heyes; C. A. Garcia; A. J. Tahmoush
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 791 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
physicians in New Mexico notified the New Mexico Department of Health and Environment of 3 patients with marked eosinophilia and severe. incapacitating myalgia who had been taking the amino acid L-tryptophan (orally) and whose illness, after thorough clinical evaluation, seemed both unusual and obsc
The clinical constellation of leukocytosis, thrombocytosis, and low or absent stainable neutrophil alkaline phosphatase (NAP) is considered characteristic of chronic myelogenous leukemia (CML) [l]. CML with eosinophilic differentiation (eosinophilic leukemia) is well described [2], and leukemia and
High titers of serum antibodies to neural antigens occur in several forms of neuropathy. These include neuropathies associated with monoclonal gammopathy, inflammatory polyneuropathies, and paraneoplastic neuropathies. The antibodies frequently react with glycosylated cell surface molecules, includi